Condition: TNBC - Triple-Negative Breast Cancer · Minimal Residual Disease · Sponsor: Personalis Inc.
A prospective, multicenter, observational study to evaluate the correlation of Molecular Residual Disease (MRD) detection using circulating tumor DNA guided test to pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) in stage I-III triple negative breast cancer (TNBC). Results from this study aim to improve MRD detection and disease outcomes for future patients.
This description comes directly from the study's public registry record.
Soumya Chappidi · 484-704-2599 · schappidi@criteriuminc.com
Julee Hartwell · 607-651-6273 · jhartwell@criteriuminc.com
Always discuss trial participation with your own doctor first.
| Arizona Oncology | Tucson, Arizona, United States | Recruiting |
| University of Colorado Cancer Center | Aurora, Colorado, United States | Recruiting |
| George Washington University | Washington D.C., District of Columbia, United States | Recruiting |
| Mount Sinai Medical Center of Florida | Miami Beach, Florida, United States | Recruiting |
| Comprehensive Hematology Oncology (ONare Alliance, LLC / Exigent Research, LLC | St. Petersburg, Florida, United States | Recruiting |
| Illinois Cancer Care | Peoria, Illinois, United States | Recruiting |
| Louisiana State University | New Orleans, Louisiana, United States | Recruiting |
| Trinity Health-Michigan | Ypsilanti, Michigan, United States | Recruiting |
| Nebraska Methodist | Omaha, Nebraska, United States | Recruiting |
| Stony Brook University Cancer Center | Stony Brook, New York, United States | Recruiting |
| Oregon Oncology Specialists | Salem, Oregon, United States | Recruiting |
| Cancer Care Associates of York | York, Pennsylvania, United States | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06230185